{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:29:37Z","timestamp":1764937777873},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,5]]},"DOI":"10.7759\/cureus.66180","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T12:39:23Z","timestamp":1722861563000},"source":"Crossref","is-referenced-by-count":1,"title":["Rosuvastatin-Induced Myopathy: A Case Series"],"prefix":"10.7759","author":[{"given":"Susheel K","family":"Malani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridevi","family":"Chigullapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Sujanyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30407-8","article-title":"The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990-2016","volume":"6","author":"India State-Level Disease Burden Initiative CVD Collaborators","year":"2018","unstructured":"India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990-2016. Lancet Glob Health. 2018, 6:e1339-51. 10.1016\/S2214-109X(18)30407-8","journal-title":"Lancet Glob Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2006.10.007","article-title":"Progressive myopathy with up-regulation of MHC-I associated with statin therapy","volume":"17","author":"Needham M","year":"2007","unstructured":"Needham M, Fabian V, Knezevic W, Panegyres P, Zilko P, Mastaglia FL. Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord. 2007, 17:194-200. 10.1016\/j.nmd.2006.10.007","journal-title":"Neuromuscul Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.03.004","article-title":"An assessment by the statin muscle safety task force: 2014 update","volume":"8","author":"Rosenson RS","year":"2014","unstructured":"Rosenson RS, Baker SK, Jacobson TA, Kopecky SL, Parker BA, The National Lipid Association's Muscle Safety Expert Panel. An assessment by the statin muscle safety task force: 2014 update. J Clin Lipidol. 2014, 8:S58-71. 10.1016\/j.jacl.2014.03.004","journal-title":"J Clin Lipidol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez I","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Curr Rheumatol Rep. 2018, 20:21. 10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref5","article-title":"Statin medications","author":"Sizar O","year":"2022","unstructured":"Sizar O, Khare S, Jamil RT, Talati R. Statin medications. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000434673.85515.89","article-title":"The spectrum of statin myopathy","volume":"25","author":"Mohassel P","year":"2013","unstructured":"Mohassel P, Mammen AL. The spectrum of statin myopathy. Curr Opin Rheumatol. 2013, 25:747-52. 10.1097\/01.bor.0000434673.85515.89","journal-title":"Curr Opin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1440206","article-title":"Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations","volume":"14","author":"Selva-O\u2019Callaghan A","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Alvarado-Cardenas M, Pinal-Fern\u00e1ndez I, et al.. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations. Expert Rev Clin Immunol. 2018, 14:215-24. 10.1080\/1744666X.2018.1440206","journal-title":"Expert Rev Clin Immunol"},{"key":"ref8","unstructured":"Petition to ban cholesterol-lowering drug rosuvastatin (Crestor). (2004). https.\/\/www.citizen.org\/article\/petition-to-ban-cholesterol-lowering-drug-rosuvastatin-crestor\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12367","article-title":"Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment","volume":"78","author":"van Staa TP","year":"2014","unstructured":"van Staa TP, Carr DF, O'Meara H, McCann G, Pirmohamed M. Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment. Br J Clin Pharmacol. 2014, 78:649-59. 10.1111\/bcp.12367","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2047487318776831","article-title":"Statins for primary prevention and rhabdomyolysis: a nationwide cohort study in France","volume":"26","author":"Coste J","year":"2019","unstructured":"Coste J, Billionnet C, Rudnichi A, Pouchot J, Dray-Spira R, Giral P, Zureik M. Statins for primary prevention and rhabdomyolysis: a nationwide cohort study in France. Eur J Prev Cardiol. 2019, 26:512-21. 10.1177\/2047487318776831","journal-title":"Eur J Prev Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70246-3","article-title":"Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial","volume":"3","author":"de Zeeuw D","year":"2015","unstructured":"de Zeeuw D, Anzalone DA, Cain VA, et al.. Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial. Lancet Diabetes Endocrinol. 2015, 3:181-90. 10.1016\/S2213-8587(14)70246-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2019.01.003","article-title":"Risk of statin-induced hypertransaminasemia: a systematic review and meta-analysis of randomized controlled trials","volume":"3","author":"Villani R","year":"2019","unstructured":"Villani R, Navarese EP, Cavallone F, et al.. Risk of statin-induced hypertransaminasemia: a systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc Innov Qual Outcomes. 2019, 3:131-40. 10.1016\/j.mayocpiqo.2019.01.003","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a2286","article-title":"Statin induced myopathy","volume":"337","author":"Sathasivam S","year":"2008","unstructured":"Sathasivam S, Lecky B. Statin induced myopathy. BMJ. 2008, 337:a2286. 10.1136\/bmj.a2286","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2008.11.002","article-title":"Low serum 25 (OH) vitamin D levels (*32 ng\/mL) are associated with reversible myositis-myalgia in statin-treated patients","volume":"153","author":"Ahmed W","year":"2009","unstructured":"Ahmed W, Khan N, Glueck CJ, et al.. Low serum 25 (OH) vitamin D levels (*32 ng\/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res. 2009, 153:11-16. 10.1016\/j.trsl.2008.11.002","journal-title":"Transl Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.11.012","article-title":"Vitamin D status modifies the association between statin use and musculoskeletal pain: a population based study","volume":"238","author":"Morioka TY","year":"2015","unstructured":"Morioka TY, Lee AJ, Bertisch S, Buettner C. Vitamin D status modifies the association between statin use and musculoskeletal pain: a population based study. Atherosclerosis. 2015, 238:77-82. 10.1016\/j.atherosclerosis.2014.11.012","journal-title":"Atherosclerosis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03448.x","article-title":"Vitamin D insufficiency - a novel mechanism of statin-induced myalgia?","volume":"71","author":"Lee P","year":"2009","unstructured":"Lee P, Greenfield JR, Campbell LV. Vitamin D insufficiency - a novel mechanism of statin-induced myalgia?. Clin Endocrinol (Oxf). 2009, 71:154-5. 10.1111\/j.1365-2265.2008.03448.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04321.x","article-title":"Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins","volume":"77","author":"Kurnik D","year":"2012","unstructured":"Kurnik D, Hochman I, Vesterman-Landes J, et al.. Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins. Clin Endocrinol (Oxf). 2012, 77:36-41. 10.1111\/j.1365-2265.2011.04321.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.04.037","article-title":"A comparison of 25-hydroxyvitamin D serum levels among those with or without statin-associated myalgias","volume":"218","author":"Backes JM","year":"2011","unstructured":"Backes JM, Barnes BJ, Ruisinger JF, Moriarty PM. A comparison of 25-hydroxyvitamin D serum levels among those with or without statin-associated myalgias. Atherosclerosis. 2011, 218:247-9. 10.1016\/j.atherosclerosis.2011.04.037","journal-title":"Atherosclerosis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256326-rosuvastatin-induced-myopathy-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T12:39:28Z","timestamp":1722861568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256326-rosuvastatin-induced-myopathy-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.66180","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,5]]}}}